NCT01701843View on ClinicalTrials.gov

Cromoglicate in Mastocytosis

PHASE2TerminatedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions
Mastocytosis
Interventions
DRUG

Cromoglicate

Twice daily topical treatment for 14 days

DRUG

Placebo

Twice daily topical treatment for 14 days

Trial Locations (1)

D-10117

Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Berlin

Sponsors

Lead Sponsor

LEO Pharma
All Listed Sponsors
lead

LEO Pharma

INDUSTRY